-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。CAKEは第1四半期の調整後EPSが1.05ドルとなり、前年同期比13%増、市場予想の1.01ドルを上回りました。総売上高は9億7,900万ドルで、5.6%増、市場予想の9億6,500万ドルも上回りました。調整後営業利益は5,700万ドル(7%増)で、市場予想の5,500万ドルを上回りました。食品費と人件費がそれぞれ5%上昇したにもかかわらず、営業利益率は5.8%で安定しました。これは3四半期連続の利益率安定を示しており、経営陣による従業員維持とサプライチェーン改善策が変動するコストを相殺し、天候の影響にもかかわらず予想を上回る業績を達成したことで、事業レバレッジが発揮されたことを示しています。経営陣は、2026年に最大26店舗の新規出店計画を再確認しました。これには、チーズケーキファクトリー最大6店舗、ノースイタリア、フラワーチャイルド、FRCの複数店舗が含まれます。同社は6億160万ドルの潤沢な流動性を維持し、未払い債務はなく、1920万ドルの自社株買いと四半期配当0.30ドルを通じて資本を還元した。これは、キャッシュ創出に対する自信を反映している。
Related Articles
Electro Optic Systems Reports Contract Backlog Growth as of March 31
Electro Optic Systems Holdings (ASX:EOS) reported a contract backlog of AU$518 million as of March 31, up 13% from the end of 2025, according to a Thursday filing with the Australian bourse.The company closed the March quarter with unrestricted cash holdings of AU$95.1 million, representing a decrease of AU$11.8 million from the end of 2025, per the filing.
Regis Healthcare Expects Fiscal 2026 Underlying EBITDA at Top End of Guidance
Regis Healthcare (ASX:REG) said it expects fiscal 2026 underlying earnings before interest, taxes, depreciation, and amortization (EBITDA) of about AU$135 million, at the top end of guidance, according to a Thursday Australian bourse filing.Occupancy across mature homes averaged about 96% in the fiscal third quarter, per the filing.The company said it generated net refundable accommodation deposit (RAD) cash inflows of AU$44.5 million in the third quarter, taking the total net RAD cash inflows for the year to date to AU$223 million.As resident turnover occurs, the progressive repricing of existing paid-up RADs to current advertised room prices is expected to generate net operating cash inflows of about AU$400 million over time while also increasing RAD retention earnings, the company added.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Mondelez International
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price of $63, raised $1, reflects a 19x multiple of projected 2027 EPS, in line with MDLZ's historical forward P/E average. We raise our 2026 EPS estimate by $0.06 to $3.08, but cut 2027's by $0.11 to $3.32. We continue to see headwinds related to chocolate and biscuits divisions, though favorable forex has been helping to a degree. MDLZ highlighted plans to stimulate growth with more promotional activity, which could boost revenues (we see an acceleration in revenues in 2027), but may come with the trade-off of narrower margins. We note that cost-saving efforts can also contribute to staving off some of the margin pressure. MDLZ is largely hedged on its cocoa input costs for 2026 but less so in 2027. Thus, if the substantial rise in cocoa pricing in 2025 does not reemerge, it should help the bottom line in 2027 as cost pressures should ease. Share buybacks have also contributed to EPS, and we note that Q1 2026 share count was down 1.5% from one year earlier.